How are TVTX butterfly max profit and max loss calculated?

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the TVTX butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 48.70%), the computed maximum profit is $194.18 per contract and the computed maximum loss is -$40.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a TVTX butterfly?

The breakeven for the TVTX butterfly priced on this page is roughly $60.40 and $64.62 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The TVTX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 13.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current TVTX implied volatility affect this butterfly?

TVTX ATM IV is at 48.70% with IV rank near 2.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

TVTX Butterfly Strategy

TVTX (Travere Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II). Sparsentan received accelerated FDA approval in February 2023 and full approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) at risk of progression. In April 2026, the FDA approved FILSPARI to reduce proteinuria in adult and pediatric patients aged 8 and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome, making it the first and only FDA-approved medicine for FSGS. The company also markets Thiola and Thiola EC (tiopronin tablets) for cystinuria, a rare genetic disorder causing recurring kidney stones. Its pipeline includes pegtibatinase, an investigational enzyme replacement therapy for classical homocystinuria (HCU).

TVTX (Travere Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.78B, a beta of 1.04 versus the broader market, a 52-week range of 17.05-66.24, average daily share volume of 2.3M, a public-listing history dating back to 2012, approximately 497 full-time employees. These structural characteristics shape how TVTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.04 places TVTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a butterfly on TVTX?

A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.

TVTX snapshot

As of August 14, 2026, spot at $62.34, ATM IV 48.70%, IV rank 2.22%, expected move 13.96%. The butterfly on TVTX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this butterfly structure on TVTX specifically: TVTX IV at 48.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a TVTX butterfly, with a market-implied 1-standard-deviation move of approximately 13.96% (roughly $8.70 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TVTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on TVTX should anchor to the underlying notional of $62.34 per share and to the trader's directional view on TVTX stock.

TVTX butterfly setup

The TVTX butterfly below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TVTX at $62.34 on that close, the first option leg uses a $60.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TVTX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TVTX shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$60.00	$4.90
Sell 2	Call	$62.50	$3.50
Buy 1	Call	$65.00	$2.50

TVTX butterfly risk and reward

Net Premium / Debit: -$40.00
Max Profit (per contract): $194.18
Max Loss (per contract): -$40.00
Breakeven(s): $60.40, $64.62
Risk / Reward Ratio: 4.854

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.

TVTX butterfly payoff curve

Modeled P&L at expiration across a range of underlying prices for the butterfly on TVTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$40.00
$13.79	-77.9%	-$40.00
$27.58	-55.8%	-$40.00
$41.36	-33.7%	-$40.00
$55.14	-11.5%	-$40.00
$68.92	+10.6%	-$40.00
$82.71	+32.7%	-$40.00
$96.49	+54.8%	-$40.00
$110.27	+76.9%	-$40.00
$124.05	+99.0%	-$40.00

When traders use butterfly on TVTX

Butterflies on TVTX are pinning bets - traders use them when they expect TVTX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.

TVTX thesis for this butterfly

The market-implied 1-standard-deviation range for TVTX extends from approximately $53.64 on the downside to $71.04 on the upside. A TVTX long call butterfly is a pinning play: it pays maximum at the middle strike if TVTX settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current TVTX IV rank near 2.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TVTX at 48.70%. As a Healthcare name, TVTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TVTX-specific events.

TVTX butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TVTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TVTX alongside the broader basket even when TVTX-specific fundamentals are unchanged. Always rebuild the position from current TVTX chain quotes before placing a trade.

Frequently asked questions

What is a butterfly on TVTX?: A butterfly on TVTX is the butterfly strategy applied to TVTX (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With TVTX stock at $62.34 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed TVTX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are TVTX butterfly max profit and max loss calculated?: Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the TVTX butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 48.70%), the computed maximum profit is $194.18 per contract and the computed maximum loss is -$40.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a TVTX butterfly?: The breakeven for the TVTX butterfly priced on this page is roughly $60.40 and $64.62 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The TVTX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 13.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a butterfly on TVTX?: Butterflies on TVTX are pinning bets - traders use them when they expect TVTX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
How does current TVTX implied volatility affect this butterfly?: TVTX ATM IV is at 48.70% with IV rank near 2.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.